{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:33:07Z","timestamp":1788395587646,"version":"build-2803163510"},"reference-count":20,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>Bilateral mastectomy for chest masculinization is one of the gender-affirming procedures for transmasculine individuals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To optimize gross handling protocols and assess histopathologic findings in transmasculine breast tissue specimens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>We identified all gender-affirming mastectomies from 2015 to 2018. We sequentially identified reduction mammoplasty (RM) cases for macromastia from the same period as control. Significant findings were defined as atypical ductal or lobular hyperplasia (ADH, ALH), ductal or lobular carcinoma in situ (DCIS, LCIS), or invasive carcinoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>Significant findings were present in 6 of 211 gender-affirming mastectomies (2.8%) as follows: ADH (n = 5) and LCIS together with ALH (n = 1). By comparison, 19 of 273 RM specimens (7%) yielded significant findings as follows: ALH (n = 11), ADH (n = 4), LCIS (n = 2), DCIS (n = 1), and invasive lobular carcinoma (n = 1). In the gender-affirming group, 142 transmen underwent androgen therapy before surgery, of whom 2 had significant pathologic findings. Thirty and 41 individuals had a family history of breast cancer in the gender-affirming and RM group, of whom 1 and 3 individuals had significant pathologic findings, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>Our study demonstrates that we handle transmasculine mastectomy specimens by examining 2.8 times more slides on average than for RMs, with a 2.5 times lower rate of significant pathologic findings. Prior family history of breast cancer or the use of androgen therapy before surgery in gender-affirming individuals did not increase the risk of identifying significant breast lesions. We recommend submitting 4 tissue blocks per mastectomy for individuals undergoing gender-affirming breast surgery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2019-0316-oa","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T17:40:06Z","timestamp":1575913206000},"page":"888-893","source":"Crossref","is-referenced-by-count":31,"title":["Pathologic Evaluation of Breast Tissue From Transmasculine Individuals Undergoing Gender-Affirming Chest Masculinization"],"prefix":"10.5858","volume":"144","author":[{"given":"Andrea","family":"Hernandez","sequence":"first","affiliation":[{"name":"From the Department of Pathology (Dr Hernandez, Dr Schwartz, Ms Warfield, and Drs Thomas, Ozerdem, and Darvishian), Women's Health Pathology (Drs Hernandez and Darvishian), and the Department of Plastic Surgery (Dr Bluebond-Langner), NYU Langone Health, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Schwartz","sequence":"additional","affiliation":[{"name":"From the Department of Pathology (Dr Hernandez, Dr Schwartz, Ms Warfield, and Drs Thomas, Ozerdem, and Darvishian), Women's Health Pathology (Drs Hernandez and Darvishian), and the Department of Plastic Surgery (Dr Bluebond-Langner), NYU Langone Health, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Warfield","sequence":"additional","affiliation":[{"name":"From the Department of Pathology (Dr Hernandez, Dr Schwartz, Ms Warfield, and Drs Thomas, Ozerdem, and Darvishian), Women's Health Pathology (Drs Hernandez and Darvishian), and the Department of Plastic Surgery (Dr Bluebond-Langner), NYU Langone Health, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen M.","family":"Thomas","sequence":"additional","affiliation":[{"name":"From the Department of Pathology (Dr Hernandez, Dr Schwartz, Ms Warfield, and Drs Thomas, Ozerdem, and Darvishian), Women's Health Pathology (Drs Hernandez and Darvishian), and the Department of Plastic Surgery (Dr Bluebond-Langner), NYU Langone Health, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Bluebond-Langner","sequence":"additional","affiliation":[{"name":"From the Department of Pathology (Dr Hernandez, Dr Schwartz, Ms Warfield, and Drs Thomas, Ozerdem, and Darvishian), Women's Health Pathology (Drs Hernandez and Darvishian), and the Department of Plastic Surgery (Dr Bluebond-Langner), NYU Langone Health, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugur","family":"Ozerdem","sequence":"additional","affiliation":[{"name":"From the Department of Pathology (Dr Hernandez, Dr Schwartz, Ms Warfield, and Drs Thomas, Ozerdem, and Darvishian), Women's Health Pathology (Drs Hernandez and Darvishian), and the Department of Plastic Surgery (Dr Bluebond-Langner), NYU Langone Health, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farbod","family":"Darvishian","sequence":"additional","affiliation":[{"name":"From the Department of Pathology (Dr Hernandez, Dr Schwartz, Ms Warfield, and Drs Thomas, Ozerdem, and Darvishian), Women's Health Pathology (Drs Hernandez and Darvishian), and the Department of Plastic Surgery (Dr Bluebond-Langner), NYU Langone Health, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","published-online":{"date-parts":[[2019,12,9]]},"reference":[{"key":"2021032422293780600_i1543-2165-144-7-888-b01","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association, DSM-5 Task Force. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th ed. Arlington, VA: American Psychiatric Association;2013; xliv.","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"3","key":"2021032422293780600_i1543-2165-144-7-888-b02","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41379-018-0117-4","article-title":"Histopathologic findings in breast surgical specimens from patients undergoing female-to-male gender reassignment surgery","volume":"32","author":"Torous","year":"2019","journal-title":"Mod Pathol"},{"issue":"7","key":"2021032422293780600_i1543-2165-144-7-888-b03","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/bjs.10794","article-title":"Routine histopathological examination after female-to-male gender-confirming mastectomy","volume":"105","author":"Van Renterghem","year":"2018","journal-title":"Br J Surg"},{"issue":"6","key":"2021032422293780600_i1543-2165-144-7-888-b04","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/his.13299","article-title":"Clinicopathological findings in female-to-male gender-affirming breast surgery","volume":"71","author":"East","year":"2017","journal-title":"Histopathology"},{"issue":"12","key":"2021032422293780600_i1543-2165-144-7-888-b05","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00595-007-3758-3","article-title":"Clinicopathological study of breast tissue in female-to-male transsexuals","volume":"38","author":"Kuroda","year":"2008","journal-title":"Surg Today"},{"key":"2021032422293780600_i1543-2165-144-7-888-b06","unstructured":"Lakhani\n              SR\n            , EllisIO, SchnittSJ, TanPH, van de VijverMJ. \n          WHO Classification of Tumours of the Breast. 4th ed. Lyon, France: IARC Press;2012. World Health Organization Classification of Tumours; vol 4."},{"issue":"4","key":"2021032422293780600_i1543-2165-144-7-888-b07","first-page":"e1738","article-title":"Trends in gender-affirming surgery in insured patients in the United States","volume":"6","author":"Lane","year":"2018","journal-title":"Plast Reconstr Surg"},{"issue":"11","key":"2021032422293780600_i1543-2165-144-7-888-b08","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.5858\/arpa.2016-0492-OA","article-title":"Recommendations for pathologic evaluation of reduction mammoplasty specimens: a prospective study with systematic tissue sampling","volume":"141","author":"Ambaye","year":"2017","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"2021032422293780600_i1543-2165-144-7-888-b09","doi-asserted-by":"crossref","first-page":"NP178","DOI":"10.1093\/asj\/sjy295","article-title":"Is histological evaluation of reduction mammaplasty specimens worthwhile?","volume":"39","author":"Demirdover","year":"2019","journal-title":"Aesthet Surg J."},{"issue":"1","key":"2021032422293780600_i1543-2165-144-7-888-b10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/SAP.0000000000001482","article-title":"A risk-stratified comparison of high-risk findings in reduction mammoplasty","volume":"81","author":"Dreifuss","year":"2018","journal-title":"Ann Plast Surg"},{"issue":"8","key":"2021032422293780600_i1543-2165-144-7-888-b11","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00268-017-3920-z","article-title":"Breast cancer detection by preoperative imaging in reduction mammaplasty patients: a single center study of 918 patients","volume":"41","author":"Merkkola-von Schantz","year":"2017","journal-title":"World J Surg"},{"issue":"4","key":"2021032422293780600_i1543-2165-144-7-888-b12","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.rbmo.2009.12.021","article-title":"Histology of genital tract and breast tissue after long-term testosterone administration in a female-to-male transsexual population","volume":"20","author":"Grynberg","year":"2010","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"2021032422293780600_i1543-2165-144-7-888-b13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/path.1711700107","article-title":"An immunohistochemical study of the long-term effects of androgen administration on female-to-male transsexual breast: a comparison with normal female breast and male breast showing gynaecomastia","volume":"170","author":"Burgess","year":"1993","journal-title":"J Pathol"},{"issue":"6","key":"2021032422293780600_i1543-2165-144-7-888-b14","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jsxm.2016.03.371","article-title":"A European network for the investigation of gender incongruence: endocrine part","volume":"13","author":"Dekker","year":"2016","journal-title":"J Sex Med"},{"issue":"3","key":"2021032422293780600_i1543-2165-144-7-888-b15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2559.1985.tb02445.x","article-title":"Breast reductions: what to do with all the tissue specimens?","volume":"9","author":"Bondeson","year":"1985","journal-title":"Histopathology"},{"issue":"1","key":"2021032422293780600_i1543-2165-144-7-888-b16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10549-018-4962-0","article-title":"Pathologic findings in reduction mammoplasty specimens: a surrogate for the population prevalence of breast cancer and high-risk lesions","volume":"173","author":"Acevedo","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"2021032422293780600_i1543-2165-144-7-888-b17","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1245\/ASO.2005.11.027","article-title":"Evaluation of residual glandular tissue after skin-sparing mastectomies","volume":"12","author":"Torresan","year":"2005","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"2021032422293780600_i1543-2165-144-7-888-b18","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/tbj.12994","article-title":"Missing targets after nipple-sparing mastectomy: a multi-disciplinary approach to avoid an undesirable outcome","volume":"24","author":"Zeng","year":"2018","journal-title":"Breast J"},{"issue":"5","key":"2021032422293780600_i1543-2165-144-7-888-b19","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jamcollsurg.2006.07.015","article-title":"Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem?","volume":"203","author":"Sacchini","year":"2006","journal-title":"J Am Coll Surg"},{"issue":"5","key":"2021032422293780600_i1543-2165-144-7-888-b20","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/PAS.0000000000000180","article-title":"Prophylactic nipple-sparing mastectomy leaves more terminal duct lobular units in situ as compared with skin-sparing mastectomy","volume":"38","author":"van Verschuer","year":"2014","journal-title":"Am J Surg Pathol"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/144\/7\/888\/2797194\/arpa_2019-0316-oa.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/144\/7\/888\/2797194\/arpa_2019-0316-oa.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:41:05Z","timestamp":1764790865000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/144\/7\/article-p888.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,9]]},"references-count":20,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,12,9]]},"published-print":{"date-parts":[[2020,7,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2019-0316-oa","relation":{},"ISSN":["0003-9985","1543-2165"],"issn-type":[{"value":"0003-9985","type":"print"},{"value":"1543-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,9]]}}}